(S)-Fmoc-2-amino-3-propargyloxy-propionic acid, 99.0%, 250mg

(R)-Methyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 98%, 100mg

N-Cbz-6-Amino-hexan-1-ol, 95.0%, 1g

(R)-N-Benzyl-1-(naphthalen-1-yl)ethanamine hydrochloride, 95.0%, 1g

2-Bromo-7-chlorobenzo[b]thiophene, 97%, 100mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine, 95.0%, 5g

4-Bromo-3-chloro-benzoic acid ethyl ester, 95.0%, 5g

Ethyl 1H-indole-5-carboxylate, 98.0%, 25g

4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid, 95.0%, 500g

2-(2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethoxy)ethanamine, 97%, 1g

Tubo TYGON® LMT-55, 3,2 mm, 6,4 mm, 15 m

4-Fluoroaniline Hydroiodide>98.0%(T)(HPLC)1g

1-ethyl-2-oxo-1,2-dihydro-4-pyridinecarboxylic acid, 95.0%, 1g